Société Laboratory Corporation of America Holdings
Actions
LH
US50540R4092
Installations et services en soins de santé
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
210,6 USD | -1,19 % | +1,41 % | -7,35 % |
Métier
- prestations de services de laboratoires cliniques (63,9%) : réalisation de tests de routine, de diagnostics de patients et prestations de surveillance et de traitement des maladies, etc. ;
- prestations de services de développement et d'essais cliniques (36,1%) : à destination des entreprises pharmaceutiques, biotechnologiques, de dispositifs médicaux et de diagnostics.
La répartition géographique du CA est la suivante : Amérique du Nord (81,2%), Europe (12,7%) et autres (6,1%).
Nombre d'employés: 61 975
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
Diagnostics Laboratories
77,4
%
| 9 204 | 61,9 % | 9 415 | 77,4 % | +2,30 % |
Biopharma Laboratory Services
22,8
%
| 5 710 | 38,4 % | 2 774 | 22,8 % | -51,42 % |
Intercompany Eliminations and Other
-0,2
%
| -37 | -0,2 % | -28 | -0,2 % | -24,93 % |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
83,7
%
| 11 531 | 77,5 % | 10 178 | 83,7 % | -11,73 % |
Europe
9,0
%
| 1 934 | 13,0 % | 1 095 | 9,0 % | -43,40 % |
Other
4,0
%
| 1 041 | 7,0 % | 486 | 4,0 % | -53,29 % |
North America
3,3
%
| 371 | 2,5 % | 403 | 3,3 % | +8,61 % |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Adam Schechter
CEO | Chief Executive Officer | 58 | 01/04/13 |
Glenn Eisenberg
DFI | Director of Finance/CFO | 63 | 16/06/14 |
Compliance Officer | 65 | 01/02/19 | |
Mark Schroeder
COO | Chief Operating Officer | 63 | 01/05/07 |
Lance Berberian
CTO | Chief Tech/Sci/R&D Officer | 61 | 01/02/14 |
Brian Caveney
CTO | Chief Tech/Sci/R&D Officer | 50 | 25/09/17 |
Chief Tech/Sci/R&D Officer | - | - | |
Henry Dong
PRN | Corporate Officer/Principal | - | - |
George Maha
PRN | Corporate Officer/Principal | - | - |
Earle Collum
PRN | Corporate Officer/Principal | - | - |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Adam Schechter
CEO | Chief Executive Officer | 58 | 01/04/13 |
Peter Neupert
BRD | Director/Board Member | 68 | 01/01/13 |
Kerrii Anderson
BRD | Director/Board Member | 66 | 17/05/06 |
Jeffrey Davis
BRD | Director/Board Member | 61 | 01/12/19 |
Paul Rothman
BRD | Director/Board Member | 66 | 06/06/23 |
Garheng Kong
BRD | Director/Board Member | 49 | 01/12/13 |
Richelle Parham
BRD | Director/Board Member | 56 | 08/02/16 |
D. Gilliland
BRD | Director/Board Member | 69 | 01/04/14 |
Kathryn Wengel
BRD | Director/Board Member | 58 | 25/03/21 |
Director/Board Member | 57 | 12/10/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 84 293 628 | 84 000 632 ( 99,65 %) | 0 | 99,65 % |
Coordonnées société
Laboratory Corp. of America Holdings
358 South Main Street
27215-5837, Burlington
+336 229 1127
http://www.labcorp.comSociétés du groupe
Nom | Catégorie et Secteur |
---|---|
Miscellaneous Commercial Services
| |
Labcorp Early Development Laboratories Ltd.
Labcorp Early Development Laboratories Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Fortrea Holdings, Inc., Labcorp Early Development Laboratories Ltd. is a British company that provides early-stage and late-stage product development services. The company is based in Harrogate, UK. Labcorp Early Development Laboratories was founded in 1974. |
Miscellaneous Commercial Services
|
Fortrea Development Ltd.
Fortrea Development Ltd. Miscellaneous Commercial ServicesCommercial Services Part of Fortrea Holdings, Inc., Fortrea Development Ltd. is a British company that provides clinical development services. The company is based in Maidenhead, UK. |
Miscellaneous Commercial Services
|
Labcorp International Holdings BV
| |
Pharmaceuticals: Major
| |
Chiltern International Ltd.
Chiltern International Ltd. Miscellaneous Commercial ServicesCommercial Services Chiltern International, Inc. provides clinical research services. It offers clinical development, medical and scientific affairs, data and analysis, pharmacovigilance and strategic regulatory services. The firm serves biotech, pharmaceuticals, biosimilars and biologics and medical device and diagnostics industries. The company was founded in 1982 and is headquartered in Slough, the United Kingdom. |
Miscellaneous Commercial Services
|
Dynacare-Gamma Laboratory Partnership
Dynacare-Gamma Laboratory Partnership Medical/Nursing ServicesHealth Services Gamma-Dynacare Medical Laboratories Inc, Providing Information, Impacting Lives, Caring for People. By living this mission, Gamma-Dynacare Medical Laboratories will achieve its vision of becoming the trusted leader in transforming laboratory information and services into solutions that improve health, wellness and the Canadian health care system. Gamma-Dynacare is one of Canada's largest and most respected providers of laboratory services and solutions, with more than 50 years of experience serving Canadians. Each day, they support tens of thousands of patients, healthcare professionals and public and private sector clients with the efficient collection and transportation of specimens, accurate testing in their state-of-the-art laboratories and prompt reporting of results. |
Medical/Nursing Services
|
Clearstone Holdings (International) Ltd.
Clearstone Holdings (International) Ltd. Financial ConglomeratesFinance Part of Laboratory Corp. of America Holdings, Clearstone Holdings (International) Ltd. functions as an investment holding British company. The company is based in London, UK. |
Financial Conglomerates
|
Labcorp International Holdings Ltd.
Labcorp International Holdings Ltd. Financial ConglomeratesFinance Chiltern International Holdings Ltd. operates as an investment holding firm. The company was founded on January 12, 1996 and is headquartered in Maidenhead, the United Kingdom. |
Financial Conglomerates
|
Secteur
Ventes par activité
Ventes par région
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
-7,35 % | 17,75 Md | |
+19,28 % | 84,56 Md | |
-26,95 % | 72,41 Md | |
+4,65 % | 27,75 Md | |
-0,46 % | 17,11 Md | |
+4,69 % | 16,03 Md | |
+8,14 % | 13,72 Md | |
+6,59 % | 12,91 Md | |
+70,00 % | 12,55 Md | |
-1,22 % | 12,22 Md |